All Photos(1)



Brij® L23 solution

30 % (w/v) in H2O

C12E23, Brij® 35 solution, Polyoxyethylene (23) lauryl ether
CAS Number:
MDL number:
PubChem Substance ID:

Quality Level



mol wt

~1198.0 g/mol


30 % (w/v) in H2O

aggregation number



91 μM

transition temp

cloud point ≥100 °C



SMILES string




InChI key


Looking for similar products? Visit Product Comparison Guide

Related Categories


Brij® L23 solution has been used:
  • as a supplement of De Man, Rogosa, Sharpe (MRS) broth for monitoring bacteriocin production by lactic acid bacteria(66)
  • as a component of developing buffer for the incubation of zymogram gel for metalloproteinase quantification(67)
  • as a component of activation buffer for recombinant human hepsin(68)

Biochem/physiol Actions

Brij® L23 solution is a surfactant and is used in the nanoparticle preparation by microemulsion method.


Some bottles may appear indented due to the packaging process. This does not affect product integrity or quality.

Legal Information

Brij is a registered trademark of Croda International PLC


Exclamation markEnvironment

Signal Word


Hazard Statements

Hazard Classifications

Aquatic Chronic 1 - Eye Irrit. 2 - Skin Irrit. 2

Storage Class Code

12 - Non Combustible Liquids



Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis

Certificate of Origin

Guillaume Morin et al.
Nutrients, 11(9) (2019-09-06)
Peroxides contaminating parenteral nutrition (PN) limit the use of methionine as a precursor of cysteine. Thus, PN causes a cysteine deficiency, characterized by low levels of glutathione, the main molecule used in peroxide detoxification, and limited growth in individuals receiving...
Reverse microemulsion synthesis of CeO2 nanopowder using polyoxyethylene (23) lauryl ether as a surfactant
Pournajaf R, et al.
Ceramics International, 40(6), 8687-8692 (2014)
Darío Morais et al.
Rhinology, 50(1), 80-86 (2012-04-04)
Hereditary Haemorrhagic Telangiectasia or Rendu-Osler-Weber syndrome is a rare autosomal dominant vascular disease characterized by mucocutaneous and gastrointestinal telangiectases and localized arteriovenous malformations in lung, brain and liver. Epistaxis, due to rupture of telangiectases of the nasal mucosa, is the...
N Shadid et al.
The British journal of surgery, 99(8), 1062-1070 (2012-05-26)
New minimally invasive treatment modalities, such as ultrasound-guided foam sclerotherapy (UGFS), are becoming more popular. In a multicentre randomized controlled non-inferiority trial, the effectiveness and costs of UGFS and surgery for treatment of the incompetent great saphenous vein (GSV) were...
Amish Patel et al.
AJR. American journal of roentgenology, 199(4), 721-729 (2012-09-22)
The purpose of this review is to describe the clinical factors related to balloon-occluded retrograde transvenous obliteration, including the preparation needed, the technique and challenges, and the outcomes. Although the procedure can be performed when transjugular intrahepatic portosystemic shunt is...


Enzymatic Assay of Cathepsin B

Enzymatic Assay of Cathepsin B

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service